Literature DB >> 10085121

MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells.

J D Brown1, M R DiChiara, K R Anderson, M A Gimbrone, J N Topper.   

Abstract

Smad proteins are essential components of the intracellular signaling pathways utilized by members of the transforming growth factor-beta (TGF-beta) superfamily of growth factors. Certain Smad proteins (e.g. Smad1, -2, and -3) can act as regulated transcriptional activators, a process that involves phosphorylation of these proteins by activated TGF-beta superfamily receptors. We demonstrate that the intracellular kinase mitogen-activated protein kinase kinase kinase-1 (MEKK-1), an upstream activator of the stress-activated protein kinase/c-Jun N-terminal kinase pathway, can participate in Smad2-dependent transcriptional events in cultured endothelial cells. A constitutively active form of MEKK-1 but not mitogen-activated protein kinase kinase-1 (MEK-1) or TGF-beta-activated kinase-1, two distinct intracellular kinases, can specifically activate a Gal4-Smad2 fusion protein, and this effect correlates with an increase in the phosphorylation state of the Smad2 protein. These effects do not require the presence of the C-terminal SSXS motif of Smad2 that is the site of TGF-beta type 1 receptor-mediated phosphorylation. Activation of Smad2 by active MEKK-1 results in enhanced Smad2-Smad4 interactions, nuclear localization of Smad2 and Smad4, and the stimulation of Smad protein-transcriptional coactivator interactions in endothelial cells. Overexpression of Smad7 can inhibit the MEKK-1-mediated stimulation of Smad2 transcriptional activity. A physiological level of fluid shear stress, a known activator of endogenous MEKK-1 activity in endothelial cells, can stimulate Smad2-mediated transcriptional activity. These data demonstrate a novel mechanism for activation of Smad protein-mediated signaling in endothelial cells and suggest that Smad2 may act as an integrator of diverse stimuli in these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085121     DOI: 10.1074/jbc.274.13.8797

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II.

Authors:  S J Wicks; S Lui; N Abdel-Wahab; R M Mason; A Chantry
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  The SMRT corepressor is regulated by a MEK-1 kinase pathway: inhibition of corepressor function is associated with SMRT phosphorylation and nuclear export.

Authors:  S H Hong; M L Privalsky
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Flow-dependent Smad2 phosphorylation and TGIF nuclear localization in human aortic endothelial cells.

Authors:  Robert D Shepherd; Stephanie M Kos; Kristina D Rinker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-13       Impact factor: 4.733

Review 4.  Noncanonical TGF-β signaling during mammary tumorigenesis.

Authors:  Jenny G Parvani; Molly A Taylor; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-31       Impact factor: 2.673

Review 5.  TGFbeta-regulated transcriptional mechanisms in cancer.

Authors:  Volker Ellenrieder; Anita Buck; Thomas M Gress
Journal:  Int J Gastrointest Cancer       Date:  2002

6.  c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity.

Authors:  M Pessah; C Prunier; J Marais; N Ferrand; A Mazars; F Lallemand; J M Gauthier; A Atfi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 7.  Targeting TGF-β Signaling for Therapeutic Gain.

Authors:  Rosemary J Akhurst
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

8.  Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.

Authors:  Jinhua Li; Naomi Vittoria Campanale; Rong Jiao Liang; James Antony Deane; John Frederick Bertram; Sharon Denise Ricardo
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 9.  To (TGF)beta or not to (TGF)beta: fine-tuning of Smad signaling via post-translational modifications.

Authors:  Katharine H Wrighton; Xin-Hua Feng
Journal:  Cell Signal       Date:  2008-02-15       Impact factor: 4.315

Review 10.  The pericyte: cellular regulator of microvascular blood flow.

Authors:  Matthew E Kutcher; Ira M Herman
Journal:  Microvasc Res       Date:  2009-02-07       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.